Metraipolis › archive › dc_2fa14c7968f4

Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System — Europe PMC PMID:40981355

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40981355
DOI
10.3390/jox15050144
License (as archived)
solo-consultazione
Archived
2026-11-10T01:19:31.278Z
SHA-256 of the archived text
6aac9875dd39d642cbee2be2d73bb602a7d8aad1e49fdd7ae0cad3c97a95886a
Stable URL of this page
https://metraipolis.com/documento/dc_2fa14c7968f4

How to cite

Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System — Europe PMC PMID:40981355 — Europe PMC (en), https://europepmc.org/article/MED/40981355 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fa14c7968f4 (Metraipolis archive dc_2fa14c7968f4, sha256 6aac9875dd39d642cbee2be2d73bb602a7d8aad1e49fdd7ae0cad3c97a95886a)
BibTeX
@misc{dc2fa14c7968f4,
  title = {Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System — Europe PMC PMID:40981355},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40981355},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fa14c7968f4; sha256 6aac9875dd39d642cbee2be2d73bb602a7d8aad1e49fdd7ae0cad3c97a95886a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40981355. Agents can read the archived copy with the MCP tool read_document.